Cross Shawn
- SEC CIK
- 0001734779
In the past year, 4 open-market sale filings worth $1.52M and no purchases.
Current role at each company
- PCRX Pacira BioSciences, Inc.Chief Financial Officeras of Apr 24, 2026
- CYTH Cyclo Therapeutics, Inc.Directoras of Mar 3, 2025
- AMTI Applied Molecular Transport Inc.CEO & Chair of the Boardas of Dec 28, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.52M
- 4 filings
- Net
- −$1.52M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Cross Shawn as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PCRX Pacira BioSciences, Inc.
Chief Financial Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 24, 2026 (view filing) | Apr 23 | 1 day | Cross ShawnChief Financial Officer | SSale | −12.9K | $25.16 | −$325.6K | −10.9%105.3K after | 10b5-1 |
| Apr 22, 2026 (view filing) | Apr 20-22 | 2 days | Cross ShawnChief Financial Officer | SSale | −12.1K | $25.09 | −$302.6K | −10.3%105.3K after | 3 lots10b5-1 |
| Dec 11, 2025 (view filing) | Dec 9-10 | 2 days | Cross ShawnChief Financial Officer | SSale | −25.0K | $25.07 | −$626.8K | −30.8%56.3K after | 2 lots10b5-1 |
| Nov 13, 2025 (view filing) | Nov 10 | 3 days | Cross ShawnChief Financial Officer | SSale | −12.1K | $22.09 | −$266.4K | −17.7%56.3K after | 10b5-1 |
AMTI Applied Molecular Transport Inc.
CEO & Chair of the Board9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2023 (view filing)4:21 PM ET | Nov 22 | 2 days | Cross ShawnCEO & Chair of the Board | SSale | −110.8K | $0.1635 | −$18.1K | −16.9%545.5K after | |
| Nov 16, 2023 (view filing)5:36 PM ET | Nov 15 | 1 day | Cross ShawnCEO & Chair of the Board | SSale | −90.4K | $0.1606 | −$14.5K | −12.1%656.3K after | |
| Oct 4, 2023 (view filing)7:27 PM ET | Jun 2-Sep 5 | 124 daysLate | Cross ShawnCEO & Chair of the Board | SSale | −5.56K | $0.2334 | −$1.30K | −0.7%746.7K after | 4 lots |
| Oct 2, 2023 (view filing)7:02 PM ET | Sep 29 | 3 days | Cross ShawnCEO & Chair of the Board | SSale | −194.0K | $0.1585 | −$30.7K | −20.5%752.3K after | |
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Cross ShawnPresident & COO | SSale | −934 | $0.50 | −$467 | −1.5%60.2K after | |
| Dec 6, 2022 (view filing) | Dec 2 | 4 days | Cross ShawnPresident & COO | SSale | −3.89K | $1.05 | −$4.09K | −6.0%61.1K after | |
| Sep 6, 2022 (view filing) | Sep 1 | 5 days | Cross ShawnPresident & COO | SSale | −884 | $1.42 | −$1.26K | −1.3%65.0K after | 2 lots |
| Jun 3, 2022 (view filing) | Jun 1-2 | 2 days | Cross ShawnPresident & COO | SSale | −3.93K | $3.01 | −$11.8K | −5.6%65.9K after | 2 lots |
| Aug 23, 2021 (view filing) | Aug 19-23 | 4 days | Cross ShawnChief Financial Officer | SSale | −10.0K | $30.12 | −$301.2K | −100.0%0 after | 2 lots |